LENZ Earnings LENZ Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -1.32 | 2026-05-11 | 10-Q |
| FY 2025 | 2025-12-31 | -2.85 | 2026-03-24 | 10-K |
| Q3 2025 | 2025-09-30 | -1.65 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.06 | 2025-07-30 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.53 | 2026-05-11 | 10-Q |
| FY 2025 | 2024-12-31 | -2.34 | 2026-03-24 | 10-K |
| Q3 2025 | 2024-09-30 | -1.93 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.77 | 2025-07-30 | 10-Q |
| Q1 2025 | 2024-03-31 | -3.53 | 2025-05-07 | 10-Q |
| FY 2024 | 2023-12-31 | -35.71 | 2025-03-19 | 10-K |
| Q3 2024 | 2023-09-30 | -23.66 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -14.02 | 2024-08-14 | 10-Q |
| Q1 2024 | 2023-03-31 | -6.50 | 2024-05-08 | 10-Q |
| FY 2023 | 2022-12-31 | -1.84 | 2024-02-27 | 10-K |
| Q3 2023 | 2022-09-30 | -1.40 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.95 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.48 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -2.45 | 2023-03-20 | 10-K |
| Q3 2022 | 2021-09-30 | -2.51 | 2022-11-09 | 10-Q |
| Q2 2022 | 2021-06-30 | -8.45 | 2022-08-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.